North America Fat Reduction Market - Industry Trends and Forecast to 2030

List of Tables

North America fat reduction market is expected to reach USD 11,773.56 million by 2033 from USD 4,201.57 million in 2022, growing at a CAGR of 9.9% during the forecast period of 2023 to 2033.

Market Segmentation:

North America Fat Reduction Market, By Type (Surgical Fat Reduction, Non-Invasive Fat Reduction, and Minimally Invasive), Application (Abdominal Fat, Thighs Fat, Buttock Fat, Upper-Arm Fat, Facial Fat, and Knee Fat), Gender (Female, Male), Age Group (Adult, Geriatric, and Child), End-User (Hospitals, Multi-Specialty Clinics, Dermatology Centers, Medical Spas, and Beauty Centers), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors and Others), Country (U.S.,Canada, Mexico, Costa Rica, Dominican Republic, Panama, El Salvador, Guatemala, Honduras, Nicaragua) - Industry Trends and Forecast to 2033

Overview of North America Fat Reduction Market Dynamics

Driver
Increasing demand for minimally invasive and non-invasive procedures
Restraint
High cost of procedures
Opportunity
Customized treatment plans and integration with other aesthetic procedures

Market Players:

Soe of the key market players operating in the North America fat reduction market are listed below:

AbbVie Inc.
Cynosure
Candela Corporation
Alma Lasers
Solta Medical (Subsidiary of Bausch & Lomb Incorporated)
Merz Pharma
Cutera
MicroAire Surgical Instruments, LLC.
Others

1 INTRODUCTION 38

1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.3 OVERVIEW OF THE NORTH AMERICA FAT REDUCTION MARKET 38
1.4 CURRENCY AND PRICING 40
1.5 LIMITATIONS 40
1.6 MARKETS COVERED 41

2 MARKET SEGMENTATION 45

2.1 MARKETS COVERED 45
2.2 GEOGRAPHICAL SCOPE 46
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 DBMR TRIPOD DATA VALIDATION MODEL 47
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 50
2.6 MULTIVARIATE MODELLING 51
2.7 TYPE LIFELINE CURVE 51
2.8 DBMR MARKET POSITION GRID 52
2.9 VENDOR SHARE ANALYSIS 53
2.10 MARKET APPLICATION COVERAGE GRID 54
2.11 SECONDARY SOURCES 55
2.12 ASSUMPTIONS 55

3 EXECUTIVE SUMMARY 56

4 PREMIUM INSIGHT 58

4.1 PESTEL ANALYSIS 59
4.2 PORTER'S FIVE FORCES 60
4.3 BRAND ANALYSIS 61
- 4.3.1 KYBELLA 61

5 INDUSTRY INSIGHTS: 62

6 NORTH AMERICA FAT REDUCTION MARKET, REGULATIONS 64

6.1 U.S. 64
- 6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE: 64
- 6.1.2 POST-MARKETING SURVEILLANCE: 66
- 6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES: 66
6.2 CANADA 67
- 6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 67
- 6.2.2 LICENSING AND REGISTRATION 68
- 6.2.3 POST EXPIRY OF PATENT REGIME 68
- 6.2.4 POST-MARKETING SURVEILLANCE 68
6.3 MEXICO 69
- 6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 69
- 6.3.2 REGULATORY APPROVAL AGENCIES 69
- 6.3.3 LICENSING AND REGISTRATION 70
- 6.3.4 POST-MARKETING SURVEILLANCE 70

7 MARKET OVERVIEW 71

7.1 DRIVERS 73
- 7.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES 73
- 7.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS 74
- 7.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS 75
- 7.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES 76
7.2 RESTRAINTS 77
- 7.2.1 HIGH COST OF PROCEDURES 77
- 7.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 78
- 7.2.3 PRODUCT RECALL 78
7.3 OPPORTUNITIES 79
- 7.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES 79
- 7.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS 80
- 7.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES 82
7.4 CHALLENGES 84
- 7.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY 84
- 7.4.2 LONGER RECOVERY TIME OF THE PROCEDURE 84

8 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE 86

8.1 OVERVIEW 87
8.2 SURGICAL FAT REDUCTION 90
- 8.2.1 LIPOSUCTION 91
  - 8.2.1.1 BY TYPE 91
    - 8.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION 91
    - 8.2.1.1.2 LASER-ASSISTED LIPOSUCTION 91
    - 8.2.1.1.3 TUMESCENT LIPOSUCTION 92
    - 8.2.1.1.4 SUPER-WET TECHNIQUE 92
  - 8.2.1.2 BY APPLICATION 92
    - 8.2.1.2.1 ABDOMINAL FAT 93
    - 8.2.1.2.2 THIGHS FAT 93
    - 8.2.1.2.3 BUTTOCK FAT 93
    - 8.2.1.2.4 UPPER-ARM FAT 93
    - 8.2.1.2.5 FACIAL FAT-DEPOSITS 93
    - 8.2.1.2.5.1 SUBMENTAL AREAS 94
    - 8.2.1.2.5.2 MALAR 94
    - 8.2.1.2.5.3 MANDIBULAR 94
    - 8.2.1.2.6 KNEE FAT 94
- 8.2.2 SURGICAL REJUVENATION 94
  - 8.2.2.1 FACE LIFT 95
  - 8.2.2.2 NECK LIFT 95
- 8.2.3 CHIN IMPLANT 95
  - 8.2.3.1 SILICONE CHIN IMPLANTS 96
  - 8.2.3.2 OTHERS 96
- 8.2.4 PORUS IMPLANTS 96
  - 8.2.4.1 TEFLON 97
  - 8.2.4.2 GORE-TEX 97
  - 8.2.4.3 MEDPORE IMPLANTS 97
8.3 NON-INVASIVE FAT REDUCTION 97
- 8.3.1 CRYOLIPOLYSIS 99
  - 8.3.1.1 COOL SCULPTING 99
  - 8.3.1.2 COOL SCULPTING ELITE 99
  - 8.3.1.3 COOL TONE 99
  - 8.3.1.4 OTHERS 100
    - 8.3.1.4.1 ABDOMINAL FAT 100
    - 8.3.1.4.2 THIGHS FAT 100
    - 8.3.1.4.3 BUTTOCK FAT 100
    - 8.3.1.4.4 UPPER-ARM FAT 101
    - 8.3.1.4.5 FACIAL FAT-DEPOSITS 101
    - 8.3.1.4.6 KNEE FAT 101
- 8.3.2 ULTRASOUND 101
  - 8.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION 102
  - 8.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION 102
    - 8.3.2.2.1 ABDOMINAL FAT 102
    - 8.3.2.2.2 THIGHS FAT 102
    - 8.3.2.2.3 BUTTOCK FAT 103
    - 8.3.2.2.4 UPPER-ARM FAT 103
    - 8.3.2.2.5 FACIAL FAT-DEPOSITS 103
    - 8.3.2.2.6 KNEE FAT 103
- 8.3.3 RADIOFREQUENCY 104
  - 8.3.3.1 ABDOMINAL FAT 104
  - 8.3.3.2 THIGHS FAT 104
  - 8.3.3.3 BUTTOCK FAT 104
  - 8.3.3.4 UPPER-ARM FAT 105
  - 8.3.3.5 FACIAL FAT-DEPOSITS 105
  - 8.3.3.6 KNEE FAT 105
- 8.3.4 LOW LEVEL LASER THERAPY 105
  - 8.3.4.1 ABDOMINAL FAT 106
  - 8.3.4.2 THIGHS FAT 106
  - 8.3.4.3 BUTTOCK FAT 106
  - 8.3.4.4 UPPER-ARM FAT 106
  - 8.3.4.5 FACIAL FAT-DEPOSITS 106
  - 8.3.4.6 KNEE FAT 106
- 8.3.5 OTHERS 106
8.4 MINIMALLY INVASIVE 106
- 8.4.1 INJECTION LIPOLYSIS 108
  - 8.4.1.1 DEOXYCHOLIC ACID INJECTIONS 108
    - 8.4.1.1.1 KYBELLA/BELKYRA 109
    - 8.4.1.1.1.1 FACIAL FAT-DEPOSITS 110
    - 8.4.1.1.1.2 UPPER-ARM FAT 110
    - 8.4.1.1.1.3 ABDOMINAL FAT 110
    - 8.4.1.1.1.4 THIGHS FAT 110
    - 8.4.1.1.1.5 KNEE FAT 110
    - 8.4.1.1.1.6 BUTTOCK FAT 110
  - 8.4.1.2 PHOSPHATIDYLCHOLINE 111
    - 8.4.1.2.1 FACIAL FAT-DEPOSITS 112
    - 8.4.1.2.2 UPPER-ARM FAT 112
    - 8.4.1.2.3 ABDOMINAL FAT 112
    - 8.4.1.2.4 THIGHS FAT 112
    - 8.4.1.2.5 KNEE FAT 112
    - 8.4.1.2.6 BUTTOCK FAT 112
- 8.4.2 OTHERS 112

9 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION 113

9.1 OVERVIEW 114
9.2 ABDOMINAL FAT 117
9.3 THIGHS FAT 117
9.4 BUTTOCK FAT 118
9.5 UPPER-ARM FAT 119
9.6 FACIAL FAT-DEPOSITS 119
- 9.6.1 SUBMENTAL AREAS 120
- 9.6.2 MANDIBULAR 120
- 9.6.3 MALAR 120
9.7 KNEE FAT 121

10 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER 122

10.1 OVERVIEW 123
10.2 FEMALE 126
10.3 MALE 126

11 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP 127

11.1 OVERVIEW 128
11.2 ADULT 131
11.3 GERIATRIC 132
11.4 CHILD 132

12 NORTH AMERICA FAT REDUCTION MARKET, BY END USER 133

12.1 OVERVIEW 134
12.2 HOSPITALS 138
- 12.2.1 BY TYPE 138
  - 12.2.1.1 PRIVATE 138
  - 12.2.1.2 PUBLIC 139
- 12.2.2 BY CATEGORY 139
  - 12.2.2.1 TIER 1 139
  - 12.2.2.2 TIER 2 139
  - 12.2.2.3 TIER 3 139
12.3 MULTISPECIALTY CLINICS 140
12.4 DERMATOLOGY CENTERS 140
12.5 MEDICAL SPAS AND BEAUTY CENTERS 141
12.6 OTHERS 141

13 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL 142

13.1 OVERVIEW 143
13.2 DIRECT TENDERS 146
13.3 RETAIL SALES 146
13.4 THIRD PARTY DISTRIBUTORS 147
13.5 OTHERS 147

14 NORTH AMERICA FAT REDUCTION MARKET, BY COUNTRY 148

14.1 NORTH AMERICA 148
- 14.1.1 U.S. 152
- 14.1.2 CANADA 175
- 14.1.3 MEXICO 197
- 14.1.4 COSTA RICA 222
- 14.1.5 DOMINICAN REPUBLIC 248
- 14.1.6 PANAMA 273
- 14.1.7 EL SALVADOR 298
- 14.1.8 GUATEMALA 323
- 14.1.9 HONDURAS 347
- 14.1.10 NICARAGUA 372

15 COMPANY SHARE ANALYSIS: NORTH AMERICA 395

16 SWOT ANALYSIS 396

17 NORTH AMERICA FAT REDUCTION MARKET, COMPANY PROFILINGS 397

17.1 ABBVIE INC. 397
- 17.1.1 COMPANY SNAPSHOT 397
- 17.1.2 REVENUE ANALYSIS 397
- 17.1.3 PRODUCT PORTFOLIO 398
- 17.1.4 RECENT DEVELOPMENTS 399
17.2 CYNOSURE 400
- 17.2.1 COMPANY SNAPSHOT 400
- 17.2.2 PRODUCT PORTFOLIO 400
- 17.2.3 RECENT DEVELOPMENTS 401
17.3 ALMA LASERS 402
- 17.3.1 COMPANY SNAPSHOT 402
- 17.3.2 PRODUCT PORTFOLIO 403
- 17.3.3 RECENT DEVELOPMENT 403
17.4 CANDELA CORPORATION 404
- 17.4.1 COMPANY SNAPSHOT 404
- 17.4.2 PRODUCT PORTFOLIO 404
- 17.4.3 RECENT DEVELOPMENT 404
17.5 MERZ NORTH AMERICA, INC. 405
- 17.5.1 COMPANY SNAPSHOT 405
- 17.5.2 PRODUCT PORTFOLIO 405
- 17.5.3 RECENT DEVELOPMENTS 406
17.6 BLACK & BLACK SURGICAL 407
- 17.6.1 COMPANY SNAPSHOT 407
- 17.6.2 PRODUCT PORTFOLIO 407
- 17.6.3 RECENT DEVELOPMENT 407
17.7 BTL GROUP OF COMPANIES 408
- 17.7.1 COMPANY SNAPSHOT 408
- 17.7.2 PRODUCT PORTFOLIO 408
- 17.7.3 RECENT DEVELOPMENTS 408
17.8 BAUSCH HEALTH COMPANIES INC. 409
- 17.8.1 COMPANY SNAPSHOT 409
- 17.8.2 REVENUE ANALYSIS 409
- 17.8.3 PRODUCT PORTFOLIO 410
- 17.8.4 RECENT DEVELOPMENT 410

17.9 CUTERA 411
- 17.9.1 COMPANY SNAPSHOT 411
- 17.9.2 REVENUE ANALYSIS 411
- 17.9.3 PRODUCT PORTFOLIO 412
- 17.9.4 RECENT DEVELOPMENT 412
17.10 ERCHONIA CORPORATION 413
- 17.10.1 COMPANY SNAPSHOT 413
- 17.10.2 PRODUCT PORTFOLIO 413
- 17.10.3 RECENT DEVELOPMENT 413
17.11 FOTONA 414
- 17.11.1 COMPANY SNAPSHOT 414
- 17.11.2 PRODUCT PORTFOLIO 414
- 17.11.3 RECENT DEVELOPMENT 414
17.12 GENESIS BIOSYSTEMS, INC. 415
- 17.12.1 COMPANY SNAPSHOT 415
- 17.12.2 PRODUCT PORTFOLIO 415
- 17.12.3 RECENT DEVELOPMENT 415
17.13 HIRONIC CO., LTD. 416
- 17.13.1 COMPANY SNAPSHOT 416
- 17.13.2 REVENUE ANALYSIS 416
- 17.13.3 PRODUCT PORTFOLIO 417
- 17.13.4 RECENT DEVELOPMENT 417
17.14 IMPLANTECH 418
- 17.14.1 COMPANY SNAPSHOT 418
- 17.14.2 PRODUCT PORTFOLIO 418
- 17.14.3 RECENT DEVELOPMENTS 419
17.15 LEADERMA INC. 420
- 17.15.1 COMPANY SNAPSHOT 420
- 17.15.2 PRODUCT PORTFOLIO 420
- 17.15.3 RECENT DEVELOPMENT 420
17.16 LYNTON LASERS LTD 421
- 17.16.1 COMPANY SNAPSHOT 421
- 17.16.2 PRODUCT PORTFOLIO 421
- 17.16.3 RECENT DEVELOPMENT 421
17.17 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.) 422
- 17.17.1 COMPANY SNAPSHOT 422
- 17.17.2 REVENUE ANALYSIS 422
- 17.17.3 PRODUCT PORTFOLIO 423
- 17.17.4 RECENT DEVELOPMENT 423
17.18 MICROAIRE SURGICAL INSTRUMENTS, LLC. 424
- 17.18.1 COMPANY SNAPSHOT 424
- 17.18.2 PRODUCT PORTFOLIO 424
- 17.18.3 RECENT DEVELOPMENT 424
17.19 MOLLER MEDICAL 425
- 17.19.1 COMPANY SNAPSHOT 425
- 17.19.2 PRODUCT PORTFOLIO 425
- 17.19.3 RECENT DEVELOPMENT 425
17.20 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.) 426
- 17.20.1 COMPANY SNAPSHOT 426
- 17.20.2 PRODUCT PORTFOLIO 426
- 17.20.3 RECENT DEVELOPMENT 426
17.21 SILIMED 427
- 17.21.1 COMPANY SNAPSHOT 427
- 17.21.2 PRODUCT PORTFOLIO 427
- 17.21.3 RECENT DEVELOPMENTS 427
17.22 SURGIFORM INNOVATIVE SURGICAL PRODUCTS 428
- 17.22.1 COMPANY SNAPSHOT 428
- 17.22.2 PRODUCT PORTFOLIO 428
- 17.22.3 RECENT DEVELOPMENT 428
17.23 VENUS CONCEPT 429
- 17.23.1 COMPANY SNAPSHOT 429
- 17.23.2 REVENUE ANALYSIS 429
- 17.23.3 PRODUCT PORTFOLIO 430
- 17.23.4 RECENT DEVELOPMENT 430

18 QUESTIONNAIRE 431

19 RELATED REPORTS 435

LIST OF TABLES

TABLE 1 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S. 77
TABLE 2 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S. 77
TABLE 3 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 89
TABLE 4 NORTH AMERICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 90
TABLE 5 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 91
TABLE 6 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 92
TABLE 7 NORTH AMERICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 93
TABLE 8 NORTH AMERICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 94
TABLE 9 NORTH AMERICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 95
TABLE 10 NORTH AMERICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 96
TABLE 11 NORTH AMERICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 98
TABLE 12 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 99
TABLE 13 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 100
TABLE 14 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 101
TABLE 15 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 102
TABLE 16 NORTH AMERICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 104
TABLE 17 NORTH AMERICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 105
TABLE 18 NORTH AMERICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 107
TABLE 19 NORTH AMERICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 108
TABLE 20 NORTH AMERICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION) 109
TABLE 21 NORTH AMERICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 109
TABLE 22 NORTH AMERICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 111
TABLE 23 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 116
TABLE 24 NORTH AMERICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 120
TABLE 25 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION) 125
TABLE 26 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION) 130
TABLE 27 NORTH AMERICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION) 137
TABLE 28 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 138
TABLE 29 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION) 139
TABLE 30 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION) 145
TABLE 31 U.S. FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 152
TABLE 32 U.S. SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 152
TABLE 33 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 153
TABLE 34 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 153
TABLE 35 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 154
TABLE 36 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 155
TABLE 37 U.S. FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 155
TABLE 38 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 156
TABLE 39 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 156
TABLE 40 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 156
TABLE 41 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 157
TABLE 42 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 158
TABLE 43 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP 158
TABLE 44 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 158
TABLE 45 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 158
TABLE 46 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 159
TABLE 47 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 159
TABLE 48 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 159
TABLE 49 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 160
TABLE 50 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 160
TABLE 51 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 160
TABLE 52 U.S. CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 161
TABLE 53 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 161
TABLE 54 U.S.ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 162
TABLE 55 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 162
TABLE 56 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 162
TABLE 57 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 163
TABLE 58 U.S. RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 164
TABLE 59 U.S. LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 165
TABLE 60 U.S. MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 165
TABLE 61 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 166
TABLE 62 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 167
TABLE 63 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 167
TABLE 64 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION) 167
TABLE 65 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES) 167
TABLE 66 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP 167
TABLE 67 U.S. KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 168
TABLE 68 U.S. PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 169
TABLE 69 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 170
TABLE 70 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 170
TABLE 71 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP 171
TABLE 72 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 171
TABLE 73 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 171
TABLE 74 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP 172
TABLE 75 U.S. FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION) 172
TABLE 76 U.S. FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION) 172
TABLE 77 U.S. FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION) 173
TABLE 78 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 173
TABLE 79 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION) 174
TABLE 80 U.S. FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION) 174
TABLE 81 CANADA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 175
TABLE 82 CANADA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 175
TABLE 83 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 176
TABLE 84 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 176
TABLE 85 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 177
TABLE 86 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 178
TABLE 87 CANADA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 178
TABLE 88 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 179
TABLE 89 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 179
TABLE 90 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 179
TABLE 91 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 180
TABLE 92 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 181
TABLE 93 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP 181
TABLE 94 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 181
TABLE 95 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 181
TABLE 96 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 182
TABLE 97 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 182
TABLE 98 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 182
TABLE 99 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 183
TABLE 100 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 183
TABLE 101 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 183
TABLE 102 CANADA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 184
TABLE 103 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 184
TABLE 104 CANADAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 185
TABLE 105 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 185
TABLE 106 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 186
TABLE 107 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 186
TABLE 108 CANADA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 187
TABLE 109 CANADA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 188
TABLE 110 CANADA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 188
TABLE 111 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 189
TABLE 112 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 189
TABLE 113 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 189
TABLE 114 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION) 189
TABLE 115 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES) 190
TABLE 116 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP 190
TABLE 117 CANADA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 190
TABLE 118 CANADA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 191
TABLE 119 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 192
TABLE 120 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 192
TABLE 121 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP 193
TABLE 122 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 193
TABLE 123 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 193
TABLE 124 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP 194
TABLE 125 CANADA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION) 194
TABLE 126 CANADA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION) 194
TABLE 127 CANADA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION) 195
TABLE 128 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 195
TABLE 129 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION) 196
TABLE 130 CANADA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION) 196
TABLE 131 MEXICO FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 197
TABLE 132 MEXICO SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 197
TABLE 133 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 198
TABLE 134 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 198
TABLE 135 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 199
TABLE 136 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 200
TABLE 137 MEXICO FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 200
TABLE 138 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 201
TABLE 139 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 201
TABLE 140 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 201
TABLE 141 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 202
TABLE 142 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 203
TABLE 143 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP 203
TABLE 144 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 203
TABLE 145 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 203
TABLE 146 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 204
TABLE 147 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 205
TABLE 148 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 205
TABLE 149 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 205
TABLE 150 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 206
TABLE 151 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 206
TABLE 152 MEXICO CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 206
TABLE 153 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 207
TABLE 154 MEXICOULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 207
TABLE 155 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 208
TABLE 156 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 208
TABLE 157 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 209
TABLE 158 MEXICO RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 210
TABLE 159 MEXICO LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 211
TABLE 160 MEXICO MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 211
TABLE 161 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 212
TABLE 162 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 212
TABLE 163 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 212
TABLE 164 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION) 212
TABLE 165 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES) 213
TABLE 166 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP 213
TABLE 167 MEXICO KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 213
TABLE 168 MEXICO PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 214
TABLE 169 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 215
TABLE 170 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 216
TABLE 171 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP 216
TABLE 172 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 217
TABLE 173 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 218
TABLE 174 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP 218
TABLE 175 MEXICO FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION) 218
TABLE 176 MEXICO FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION) 219
TABLE 177 MEXICO FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION) 219
TABLE 178 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 220
TABLE 179 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION) 220
TABLE 180 MEXICO FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION) 221
TABLE 181 COSTA RICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 222
TABLE 182 COSTA RICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 222
TABLE 183 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 223
TABLE 184 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 223
TABLE 185 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 224
TABLE 186 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 225
TABLE 187 COSTA RICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 225
TABLE 188 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 226
TABLE 189 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 226
TABLE 190 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 226
TABLE 191 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 227
TABLE 192 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 228
TABLE 193 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP 228
TABLE 194 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 228
TABLE 195 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 229
TABLE 196 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 230
TABLE 197 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 230
TABLE 198 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 230
TABLE 199 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 231
TABLE 200 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 232
TABLE 201 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 232
TABLE 202 COSTA RICA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP 232

LIST OF FIGURES

FIGURE 1 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION 45
FIGURE 2 NORTH AMERICA FAT REDUCTION MARKET: DATA TRIANGULATION 47
FIGURE 3 NORTH AMERICA FAT REDUCTION MARKET: DROC ANALYSIS 48
FIGURE 4 NORTH AMERICA FAT REDUCTION MARKET: COUNTRY VS. REGIONAL MARKET ANALYSIS 49
FIGURE 5 NORTH AMERICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS 49
FIGURE 6 NORTH AMERICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS 50
FIGURE 7 NORTH AMERICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING 51
FIGURE 8 NORTH AMERICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID 52
FIGURE 9 NORTH AMERICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS 53
FIGURE 10 NORTH AMERICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID 54
FIGURE 11 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION 57
FIGURE 12 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033 58
FIGURE 13 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FAT REDUCTION MARKET IN 2023 & 2033 58
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FAT REDUCTION MARKET 72
FIGURE 15 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2022 87
FIGURE 16 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION) 88
FIGURE 17 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033) 88
FIGURE 18 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE 89
FIGURE 19 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2022 114
FIGURE 20 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION) 115
FIGURE 21 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033) 115
FIGURE 22 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE 116
FIGURE 23 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2022 123
FIGURE 24 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION) 124
FIGURE 25 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033) 124
FIGURE 26 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE 125
FIGURE 27 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2022 128
FIGURE 28 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION) 129
FIGURE 29 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033) 129
FIGURE 30 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE 130
FIGURE 31 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2022 134
FIGURE 32 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION) 135
FIGURE 33 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033) 135
FIGURE 34 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE 136
FIGURE 35 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022 143
FIGURE 36 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION) 144
FIGURE 37 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033) 144
FIGURE 38 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 145
FIGURE 39 NORTH AMERICA FAT REDUCTION MARKET: SNAPSHOT (2022) 149
FIGURE 40 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022) 150
FIGURE 41 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033) 150
FIGURE 42 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033) 151
FIGURE 43 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE (2023-2033) 151
FIGURE 44 NORTH AMERICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 395